1. Introduction {#sec1-jcm-09-00376}
===============

Health effects linked to the exposure of ambient air pollutants is a major environmental issue and results in \~3 million deaths a year, mostly due to ischaemic heart disease (\~40%), stroke (\~40%), chronic obstructive pulmonary disease (\~11%), lung cancer (\~6%) and acute lower respiratory infections (\~3%, mostly in children), according to the World Health Organization \[[@B1-jcm-09-00376]\]. In urban areas, the population is mostly exposed to combustion-linked reactive gases (NO~x~, SO~2~ and O~3~) and aerosols (i.e., particulate matter (PM)) typically containing black carbon, organics, sulphate, nitrate, ammonium, road-dust and trace metals. After this epidemiological evidence \[[@B1-jcm-09-00376]\], the medical community started to develop so-called "environmental cardiology" studies focusing (i) on understanding the pathophysiological mechanisms by which combustion PM prompts atherosclerosis and ischemic heart disease, and (ii) on identifying the role of gene-environment interactions and the pathways involved in the oxidative stress generated in vascular inflammation \[[@B2-jcm-09-00376],[@B3-jcm-09-00376],[@B4-jcm-09-00376]\]. These studies showed that inhalation of diesel exhaust soot particles promoted proatherogenic genes in vascular endothelial cells, whereas ambient ultrafine particles lead to prooxidant and proinflammatory effects prompting atherosclerosis \[[@B2-jcm-09-00376],[@B5-jcm-09-00376],[@B6-jcm-09-00376]\]. These studies contributed to identify the profile of the persons especially susceptible to combustion PM and who should take medical preventive actions \[[@B7-jcm-09-00376]\].

More recently, the scientific community started to pay attention to the health effects linked to the inhalation of desert dust aerosols \[[@B8-jcm-09-00376],[@B9-jcm-09-00376]\], especially cardiovascular disease \[[@B10-jcm-09-00376],[@B11-jcm-09-00376],[@B12-jcm-09-00376]\]. Most desert dust sources are located in the so-called "dust belt" ([Figure 1](#jcm-09-00376-f001){ref-type="fig"}), which expands through North Africa, the Middle East and to China \[[@B13-jcm-09-00376]\]. Dust from North Africa is mostly exported to the Atlantic, resulting in frequent dust concentrations within the ranges (i) thousands µg/m^3^ in western North Africa \[[@B14-jcm-09-00376]\] and (ii) tens to hundreds (µg/m^3^) in the Canary Islands \[[@B15-jcm-09-00376]\] and Cape Verde \[[@B16-jcm-09-00376]\]. Episodically, dust is exported northward across the Mediterranean, typically resulting in dust concentrations of about tens of µg/m^3^ in southern Europe (typically 10--60 µg/m^3^) \[[@B17-jcm-09-00376],[@B18-jcm-09-00376]\]. Epidemiological studies performed in cities of southern Europe found increases in cardiovascular mortality during Saharan dust events \[[@B19-jcm-09-00376]\]. The biological mechanism by which dust is associated with cardiovascular mortality remains unknown \[[@B11-jcm-09-00376],[@B12-jcm-09-00376]\].

There are two clear gaps in the studies of health effects linked to dust exposure. First, there is a need to develop studies in the population living near major dust sources. After a literature review, De Longueville et al. \[[@B20-jcm-09-00376]\] concluded that there was an imbalance between the location of the major dust sources (North Africa to Middle East) and most studied regions (southern Europe and East Asia). The highest dust concentration occurs in western North Africa, and no studies on the health effects of dust, in practice, have been performed in the region. Second, most studies have been epidemiological, associating cardiovascular mortality to dust; however, the specific heart disease involved in that cardiovascular mortality statistic is still unknown (is dust prompting angina, acute myocardial infarction, acute coronary syndrome or heart failure (HF), or several of them?); this information is vital so hospital emergency departments can prepare for when a severe dust event is forecasted. This study attempts to contribute to fill these two gaps.

The results presented here are part of a set of studies designed to identify the pathophysiological mechanisms by which exposure to desert dust aerosols blowing in the ambient air influences the prognosis of cardiovascular disease. Here we focused on HF, a chronic and progressive condition by which the heart is unable to maintain the pumping needed to provide the body's needs for blood and oxygen \[[@B21-jcm-09-00376]\]. HF is the main cause of emergencies and hospitalization in patients over the age of 65, and there is a need to identify the factors that may have led to suffer such HF events \[[@B22-jcm-09-00376]\]. The objective is to assess if exposure to desert dust aerosols influences in-hospital mortality in patients suffering from HF.

2. Materials and Methods {#sec2-jcm-09-00376}
========================

2.1. Study Region {#sec2dot1-jcm-09-00376}
-----------------

Tenerife ([Figure 1](#jcm-09-00376-f001){ref-type="fig"}) has an abrupt orography, with a mountain ridge which runs from the centre of the island (Las Cañadas, 2400 m.a.s.l., base of El Teide volcano, 3718 m.a.s.l.) toward the northeast (Anaga, reaching 1024 m.a.s.l.). Meteorology is dominated by the North Atlantic anticyclone, which prompts trade winds to blow. The main sources of air pollutants are road traffic and the Candelaria and Granadilla fuel-oil power plants. The oil refinery in Santa Cruz definitively ceased its refining activities in 2013. Levels of air pollutants are rather low, compared to continental regions of Europe \[[@B23-jcm-09-00376],[@B24-jcm-09-00376]\].

2.2. Dust Events {#sec2dot2-jcm-09-00376}
----------------

We characterised the Saharan dust events using PM~x~ measurements and dust modelling. Concentrations of PM~10~ and PM~2.5~ (PM with an aerodynamic diameter \<10 and 2.5 microns, respectively) and reactive gases are measured by the Air Quality Network of the Canary Islands by using harmonized standard methods in the European Union. We determined and analysed daily averaged values. We initially analysed data of PM~x~ collected at three sites of Tenerife, placed in the south (El Rio rural site), the northeast (Tena Artigas urban site in Santa Cruz de Tenerife) and the north (Balsa Zamora rural site, near Los Realejos).

The surface dust concentrations and dust optical depth provided by the multimodel median prediction (<https://sds-was.aemet.es/forecast-products/dust-forecasts>) of the WMO SDSWAS (World Meteorological Organization's Sand and Dust Storm Warning Advisory and Assessment System) was used to identify dust events \[[@B25-jcm-09-00376]\]. This ensemble product is generated from the forecasts provided by twelve dust prediction models (by using the poor-man approach) \[[@B26-jcm-09-00376]\]: BSC-DREAM8b, CAMS, DREAM8-NMME-MACC, NMMB/BSC-Dust, MetUM, GEOS-5, NGAC, RegCM4-EMA, DREAMABOL, NOA-WRF-CHEM, SILAM and LOTOS-EUROS. The evaluation of this dust forecast for the Canary Islands was performed by García-Castrillo and Terradellas \[[@B27-jcm-09-00376]\].

2.3. Medical Data {#sec2dot3-jcm-09-00376}
-----------------

This study was based on medical data collected in the Emergency Department of the University Hospital of the Canary Islands, Tenerife, in patients admitted with the diagnosis of HF. We studied the period from 2014 to 2017, and 829 patients were admitted with this diagnosis. The following demographics, clinical variables, HF precipitating factors, and in-hospital treatments were collected by an independent researcher ([Table 1](#jcm-09-00376-t001){ref-type="table"}): demography---age and gender;cardiovascular risk factors---dichotomous variable reporting if the patient had hypertension, was a smoker, had diabetes mellitus or hypercholesterolemia;medical history---dichotomous variable on previous HF episodes, previous chronic ischemic heart disease (IHD), atrial fibrillation or chronic obstructive pulmonary disease (COPD);biochemistry---levels of hemoglobin (g/dL), brain natriuretic peptide (BNP: pg/mL) and sodium (mg/dL) were determined by analysis of blood samples;clinical data---data on the left ventricular ejection fraction (LVEF: %), hospital stay (d) and Charlson index;HF precipitating factors---therapeutic non-compliance, rapid atrial fibrillation, infections and unknown precipitating factors;in-hospital treatment---dichotomous variable reporting if patients received treatment with furosemide, spironolactone / eplerenone, beta blockers, angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonists (ARA-II) during the period they stayed in the hospital.

2.4. Statistical Analysis {#sec2dot4-jcm-09-00376}
-------------------------

The objective was to study the in-hospital mortality, more specifically, to identify how the independent variables were associated with in-hospital HF mortality (dependent variable). As independent variables we used the medical data described above and data of PM~x~ and dust events, more specifically, the daily mean PM~10~, PM~2.5~ and PM~2.5--10~ concentrations and the occurrence of a Saharan dust resulting in a (24 h average) PM~10~ concentration \>50 µg/m^3^ (dichotomous variable). The data of PM~x~ collected at El Rio station, directly exposed to the Saharan dust events arriving to Tenerife, were used for this analysis. To compare quantitative variables, we used the Mann--Whitney U test and the Student's *t* test. To determine the association between qualitative (dichotomous) variables, the chi-square test or Fischer's exact test were used. The variable "Saharan dust event with PM~10~ 50 μg/m^3^" (24 h average) was categorized as a dichotomous variable (1 or 0). Multivariable logistic regression analysis was carried out to determine the variables associated with the presence of in-hospital mortality. Statistical analysis was performed with the SPSS program, version 20 (SPSS Inc., Armonk, NY, USA). This methodology is typically used in these types of studies \[[@B28-jcm-09-00376]\].

3. Results {#sec3-jcm-09-00376}
==========

3.1. Dust Events {#sec3dot1-jcm-09-00376}
----------------

As far as we know, this is among the first studies on dust and cardiovascular disease performed in the dust belt ([Figure 1](#jcm-09-00376-f001){ref-type="fig"}), so we first illustrated the huge impacts of Saharan desert dust on air quality. [Figure 2](#jcm-09-00376-f002){ref-type="fig"}A shows the daily average concentrations of PM~10~ on Tenerife Island during the study period (2014--2017), whereas [Figure 2](#jcm-09-00376-f002){ref-type="fig"}B shows the dust concentrations at the surface level provided by WMO SDSWAS modelling \[[@B27-jcm-09-00376]\].

Background levels of PM~10~ were usually low, with an annual 50th percentile within the range 13--17 µg/m^3^ and annual mean values with the range 18--24 µg/m^3^ at the three sites (south, north and northeast) of Tenerife plotted in [Figure 2](#jcm-09-00376-f002){ref-type="fig"}A. Previous studies \[[@B29-jcm-09-00376]\] found that the composition of PM~10~ associated with these background levels was dominated by sea salt (\~30%), fuel oil combustion (25%), vehicle exhaust (12%) and dust (12%). During Saharan dust events, PM~10~ concentrations increased from the background level to values within the ranges 35--50 µg/m^3^ (during "moderate" events), 50--100 µg/m^3^ ("intense") and 100--400 µg/m^3^ ("very intense"; [Figure 2](#jcm-09-00376-f002){ref-type="fig"}A). In these cases, PM~10~ was, by far, constituted by mineral dust \[[@B29-jcm-09-00376],[@B30-jcm-09-00376]\] (see the typical ochre colour and the chemical composition of PM~10~ samples during these events in [Figure 3](#jcm-09-00376-f003){ref-type="fig"}).

At low altitudes (near sea level), winter dust events were very frequently associated with higher dust and, consequently, PM~10~ concentrations than those of summer dust events; the measured PM~10~ ([Figure 2](#jcm-09-00376-f002){ref-type="fig"}A) and dust models ([Figure 2](#jcm-09-00376-f002){ref-type="fig"}B) reached values within the range 100--400 µg/m^3^ between November and March and within 30--100 µg/m^3^ in summertime. These differences between the winter and the summer dust events were due to the altitude at which the dusty Saharan Air Layer (SAL) arrived to Tenerife. In winter, dust transport occurs at low altitudes (approximately \<700 m.a.s.l. \[[@B31-jcm-09-00376]\]). In summertime, the dusty SAL tends to flow at higher altitudes (\~500 to 5000 m.a.s.l. \[[@B15-jcm-09-00376],[@B32-jcm-09-00376]\]); impacts at ground occur when the SAL shifts downward \[[@B33-jcm-09-00376]\]. Examples of winter and summer dust events are shown in [Figure 2](#jcm-09-00376-f002){ref-type="fig"}C,D, including the dust vertical profile. Because the core path of the SAL regularly occurs south of the Canary Islands, dusty air arrives to Tenerife under southeast airflow conditions and, consequently, PM~10~ concentrations are frequently higher in southern than in northern Tenerife (the latter also affected by the shielding effect of the orography).

3.2. Impact of Dust on In-Hospital Mortality of Patients with HF {#sec3dot2-jcm-09-00376}
----------------------------------------------------------------

We focused on the impact on HF in-hospital mortality of the Saharan dust events with PM~10~ concentrations (24 h average) higher than 50 µg/m^3^, which is the threshold value for PM~10~ recommended in the guidelines of the World Health Organization. These events were identified using WMO SDSWAS modelling ([Figure 2](#jcm-09-00376-f002){ref-type="fig"}C,D). During the study period, the threshold of 50 µg/m^3^ was exceeded on 124 days, all them associated with Saharan dust episodes.

During the study period (2014--2017), 829 patients were admitted in the Emergency Department of the University Hospital of the Canary Islands with the diagnosis of HF. From this group, a total of 49 patients expired (5.9%), whereas 780 survived, which is close to the average values in Spain (9.4% for people over 45 years \[[@B22-jcm-09-00376]\]). By applying the tests and the multivariable logistic regression analysis described in the methodology, we analysed the association of HF in-hospital mortality (dependent variable) with the demographics, cardiovascular risk, medical history, biochemistry, clinic data, HF precipitating factors, in-hospital treatments of each patient and dust events as independent variables. The results are shown in [Table 1](#jcm-09-00376-t001){ref-type="table"}. The two groups (i.e., HF mortality and HF no mortality) showed no significant differences in terms of the demographics, clinical characteristics, HF precipitating factors, and in-hospital treatment variables (*p* \> 0.05). Factors such as smoking, suffering from diabetes mellitus or hypertension, or previous COPD or HF did not differentiate deceased patients from patients that survived. However, a huge difference was obtained in terms of exposure to Saharan dust (*p* \< 0.0001; [Table 1](#jcm-09-00376-t001){ref-type="table"}). Eighty-six percent of deaths (42/49 cases) registered (2014-2017) in the HF mortality group occurred during Saharan dust episodes that resulted in PM~10~ concentrations higher than 50 μg/m^3^; more specifically, this group was exposed to PM~10~, PM~2.5~ and PM~2.5-10~ within the interquartile ranges 71--96, 23--36 and 37--69 μg/m^3^, respectively. The group of patients that suffered no HF mortality were mostly exposed to lower PM~x~ levels, with a Q3 equal to 26 μg/m^3^ for PM~10~, 12 μg/m^3^ for PM~2.5~ and 14 μg/m^3^ for PM~2.5-10~. However, about 41% of these patients were exposed to PM~10~ \> 50 μg/m^3^, that is, most of these admissions occurred during a few intense dust events. The multivariate analysis we performed in the present study showed, after adjusting for other covariates, that exposure to Saharan dust events with PM~10~ concentrations higher than 50 μg/m^3^ was an independent predictor of in-hospital mortality in patients with HF (OR = 2.79, 95% CI (1.066--7.332), *p* = 0.03).

4. Discussion {#sec4-jcm-09-00376}
=============

Recent epidemiological studies found an association between cardiovascular mortality and Saharan dust episodes affecting southern Europe. The current study is part of a set of investigations designed to identify the pathophysiological mechanisms by which exposure to desert dust aerosols prompts cardiovascular disease. A previous study showed that exposure to dust events with PM~10~ \> 50 μg/m^3^, age and key comorbidity factors (as hypertension and diabetes mellitus) were precipitating factors for hospital admission due to HF \[[@B10-jcm-09-00376]\]. In this new study we found an association between exposure to high concentrations of Saharan desert dust and in-hospital mortality of patients with HF; more specifically, we found that 86% of in-hospital HF mortality cases (2014--2017) were registered during Saharan dust episodes that resulted in PM~10~ concentrations higher than 50 μg/m^3^.

The most intense dust events mostly occur in winter, Nov to Mar ([Figure 2](#jcm-09-00376-f002){ref-type="fig"}B), so this is the period when HF mortality due to dust may occur in our study region. In other regions, dust seasons occur in different seasons (e.g. spring in the Middle East and in Asia). Thus, because the results of this study can most probably be extrapolated to other regions, and because we try to address this topic from a comprehensive point of view, we have not emphasised seasonal evolution. In other words, HF mortality due to dust will be enhanced during dust seasons, whenever they are. In summary, exposure to dust concentrations of PM~10~ \> 50 μg/m^3^ (guideline value of the World Health Organization) exacerbates HF and may result in deaths. These results are especially relevant for the dust belt, where the population is exposed to dust concentrations within the hundreds to thousands µg/m^3^ range.

The results of this and previous studies performed by our group point out that exposure to desert dust aerosols and combustion aerosols probably results in different types of cardiovascular diseases. In our study, we found an association between desert dust aerosols and HF, whereas previous studies \[[@B34-jcm-09-00376]\] found an association between combustion soot (black carbon aerosols) and ischemic heart diseases, including acute coronary syndrome. These results suggest that coarse dust particles exacerbate HF, whereas very small combustion particles tend to deposit in the coronary arteries. Consistently, epidemiological studies found that mortality was associated with fine (PM~2.5~) particles during non-Saharan dust days and with coarse (PM~2.5--10~) particles during Saharan dust days \[[@B35-jcm-09-00376]\]. Further complementary studies to understand the pathophysiological mechanisms are needed.

5. Conclusions {#sec5-jcm-09-00376}
==============

Exposure to Saharan dust events associated with PM~10~ concentrations \>50 μg/m^3^ is an independent predictor of HF in-hospital mortality.
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![Global Dust Optical Depth highlighting the location of Tenerife and of the Dust Belt (WHO, 2017).](jcm-09-00376-g001){#jcm-09-00376-f001}

![Time series of daily mean values of (**A**) PM~10~ measured at three sites of Tenerife (South, S-TF; Northeast, NE-TF; and North, N-TF) and of (**B**) surface dust concentrations provided by the World Meteorological Organization's Sand and Dust Storm Warning Advisory and Assessment System (WMO SDSWAS). Example of a typical dust event of winter (26-Dec-2016): surface dust concentrations (**C1**) and vertical dust profile in Tenerife (**C2**). Example of a typical dust event of summer (08-Aug-2017): dust optical depth (**D1**) and vertical dust profile in Tenerife (**D2**). Blue circle highlights the location of Tenerife.](jcm-09-00376-g002){#jcm-09-00376-f002}

![(**A**) Picture of a PM~10~ sample collected from the ambient air (at the rate of 30 m^3^/h during 8 h) during a Saharan dust event. The samples were collected in a filter, and the ochre colour of the samples evidenced the desert dust nature; the outer white layer is the blank part of the filter (no sample). (**B**--**D**) Mean bulk composition of PM~x~ in Tenerife during Saharan dust events according to García et al. \[[@B30-jcm-09-00376]\], highlighting the contributions of desert dust, organic matter (OM), ammonium (NH~4~^+^), nitrate (NO~3~^−^), sulphate (SO~4~^=^) and the undetermined fraction (und). The und fraction is mostly water attached to the aerosols.](jcm-09-00376-g003){#jcm-09-00376-f003}

jcm-09-00376-t001_Table 1

###### 

Baseline characteristics of the study population as a function of in-hospital mortality.

                                                                                 HF Mortality (*n* = 49)   HF no Mortality (*n* = 780)   *p*-Value
  ------------------------------------------------------------------------------ ------------------------- ----------------------------- -----------
  Age, year                                                                      73.5 ± 2                  73.8 ± 1.5                    0.25
  Female sex                                                                     13 (26.5)                 220 (28.2)                    0.80
  **Cardiovascular risk factors**                                                                                                        
  Hypertension                                                                   25 (51)                   500 (64.1)                    0.06
  Smoking                                                                        24 (49)                   413 (52.9)                    0.58
  Diabetes mellitus                                                              20 (40.8)                 339 (43.5)                    0.71
  Hypercholesterolemia                                                           30 (61.2)                 454 (58.2)                    0.67
  **Medical history**                                                                                                                    
  Previous HF episode                                                            33 (67.3)                 462 (59.2)                    0.26
  Previous chronic IHD                                                           8 (16.3)                  179 (22.9)                    0.28
  Atrial fibrillation                                                            10 (20.4)                 242 (31)                      0.11
  COPD                                                                           12 (24.5)                 126 (16.2)                    0.12
  **Biochemistry**                                                                                                                       
  Hemoglobin (g/dL)                                                              11.95 ± 1.65              11.73 ± 1.73                  0.37
  BNP (pg/mL)                                                                    1295.8 (937.8--1769)      1339.6 (925.6-1961.8)         0.29
  Sodium (mg/dL)                                                                 138.31 ± 2.88             138.32 ± 3.15                 0.98
  **Clinical data**                                                                                                                      
  LVEF (%)                                                                       49.47 ± 12.40             50.86 ± 11.04                 0.39
  Hospital stay (d)                                                              10.59 ± 3.67              10.37 ± 3.77                  0.66
  Charlson index                                                                 4.73 ± 0.78               4.71 ± 0.74                   0.84
  **HF precipitating factors**                                                                                                           0.73
  Therapeutic non-compliance                                                     2 (4)                     59 (7.9)                      
  Rapid atrial fibrillation                                                      25 (52.1)                 365 (48.8)                    
  Infections                                                                     12 (25)                   208 (27.7)                    
  Unknown precipitating factors                                                  14 (28.5)                 144 (18.4)                    
  **In-hospital treatment**                                                                                                              
  Furosemide                                                                     49 (100)                  780 (100)                     \-
  Spironolactone / Eplerenone                                                    31 (63.3)                 499 (64)                      0.92
  Beta blockers                                                                  32 (65.3)                 462 (59.5)                    0.41
  ACEI                                                                           36 (73.5)                 540 (69.2)                    0.53
  ARA-II                                                                         13 (26.5)                 240 (30.8)                    0.53
  Number of patients exposed to PM~10~ ≥ 50 μg/m^3^ during Saharan dust events   42 (85.7)                 318 (40.8)                    \<0.0001
  PM~10~ (μg/m^3^)                                                               84.7 (71.5--95.8)         15.3 (9.7--26.4)              \<0.0001
  PM~2.5~ (μg/m^3^)                                                              29.9 (23.3--36.1)         6.9 (5.6--12.5)               \<0.0001
  PM~2.5-10~ (μg/m^3^)                                                           57.6 (37.5--68.8)         8.3 (5.6--13.9)               \<0.0001

Continuous values are expressed as mean ± standard deviation or median (Q1: Q3), categorical values with n (%). ACEI, angiotensin-converting enzyme inhibitor; ARA II, angiotensin II receptor antagonists; BNP, brain natriuretic peptide; COPD, chronic obstructive pulmonary disease; HF, heart failure; IHD, ischemic heart disease; LVEF, left ventricular ejection fraction; PM, particulate matter.
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